167 related articles for article (PubMed ID: 32894851)
21. Novel Deleterious Mutation in Steroid-5α-Reductase-2 in 46, XY Disorders of Sex Development: Case Report Study.
Rafigh M; Salmaninejad A; Sorouri Khorashad B; Arabi A; Milanizadeh S; Hiradfar M; Abbaszadegan MR
Fetal Pediatr Pathol; 2022 Feb; 41(1):141-148. PubMed ID: 32449406
[No Abstract] [Full Text] [Related]
22. Clinical, Biochemical, and Molecular Characterization of Indian Children with Clinically Suspected Androgen Insensitivity Syndrome.
Kumar A; Sharma R; Faruq M; Kumar M; Sharma S; Werner R; Hiort O; Vandana J
Sex Dev; 2022; 16(1):34-45. PubMed ID: 34689141
[TBL] [Abstract][Full Text] [Related]
23. Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development.
María Guadalupe OL; Katy SP; Charmina AA; Vihko P; Marta M
Front Genet; 2021; 12():794476. PubMed ID: 35154247
[No Abstract] [Full Text] [Related]
24. Practical approach to steroid 5alpha-reductase type 2 deficiency.
Cheon CK
Eur J Pediatr; 2011 Jan; 170(1):1-8. PubMed ID: 20349245
[TBL] [Abstract][Full Text] [Related]
25. Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey.
Abacı A; Çatlı G; Kırbıyık Ö; Şahin NM; Abalı ZY; Ünal E; Şıklar Z; Mengen E; Özen S; Güran T; Kara C; Yıldız M; Eren E; Nalbantoğlu Ö; Güven A; Çayır A; Akbaş ED; Kor Y; Çürek Y; Aycan Z; Baş F; Darcan Ş; Berberoğlu M
J Endocrinol Invest; 2019 Apr; 42(4):453-470. PubMed ID: 30132287
[TBL] [Abstract][Full Text] [Related]
26. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency.
Sahu R; Boddula R; Sharma P; Bhatia V; Greaves R; Rao S; Desai M; Wakhlu A; Phadke S; Shukla M; Dabadghao P; Mehrotra RN; Bhatia E
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):247-54. PubMed ID: 19492581
[TBL] [Abstract][Full Text] [Related]
28. Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.
Batista RL; Mendonca BB
Appl Clin Genet; 2020; 13():83-96. PubMed ID: 32346305
[TBL] [Abstract][Full Text] [Related]
29. Correlation of androgen receptor and SRD5A2 gene mutations with pediatric hypospadias in 46, XY DSD children.
Fu XH; Zhang WQ; Qu XS
Genet Mol Res; 2016 Mar; 15(1):15018232. PubMed ID: 27051040
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene.
Jia W; Zheng D; Zhang L; Li C; Zhang X; Wang F; Guan Q; Fang L; Zhao J; Xu C
Endocr J; 2018 Jun; 65(6):645-655. PubMed ID: 29643321
[TBL] [Abstract][Full Text] [Related]
31. An Extremely Rare
Le PTQ; Le TNU; Nguyen TTB; Nguyen MT; Ha TMT
Case Rep Endocrinol; 2022; 2022():6025916. PubMed ID: 35386187
[No Abstract] [Full Text] [Related]
32. Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency.
Veiga-Junior NN; Medaets PA; Petroli RJ; Calais FL; de Mello MP; Castro CC; Guaragna-Filho G; Sewaybricker LE; Marques-de-Faria AP; Maciel-Guerra AT; Guerra-Junior G
Int J Endocrinol; 2012; 2012():964876. PubMed ID: 22194745
[TBL] [Abstract][Full Text] [Related]
33. Screening for mutations in 17β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46,XY disorders of sex development.
Phelan N; Williams EL; Cardamone S; Lee M; Creighton SM; Rumsby G; Conway GS
Eur J Endocrinol; 2015 Jun; 172(6):745-51. PubMed ID: 25740850
[TBL] [Abstract][Full Text] [Related]
34. Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias.
Mares L; Vilchis F; Chávez B; Ramos L
J Pediatr Urol; 2020 Oct; 16(5):689.e1-689.e12. PubMed ID: 32732174
[TBL] [Abstract][Full Text] [Related]
35. In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5α-reductase activity.
Katharopoulos E; Sauter K; Pandey AV; Flück CE
J Steroid Biochem Mol Biol; 2019 Jun; 190():263-272. PubMed ID: 30703436
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of gene mutations in a Chinese 46,XY disorders of sex development cohort detected by targeted next-generation sequencing.
Yu BQ; Liu ZX; Gao YJ; Wang X; Mao JF; Nie M; Wu XY
Asian J Androl; 2021; 23(1):69-73. PubMed ID: 32985417
[TBL] [Abstract][Full Text] [Related]
37. 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect.
Skordis N; Patsalis PC; Bacopoulou I; Sismani C; Sultan C; Lumbroso S
J Pediatr Endocrinol Metab; 2005 Mar; 18(3):241-6. PubMed ID: 15813602
[TBL] [Abstract][Full Text] [Related]
38. 46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.
Chávez B; Ramos L; Gómez R; Vilchis F
Mol Genet Genomic Med; 2014 Jul; 2(4):292-6. PubMed ID: 25077171
[TBL] [Abstract][Full Text] [Related]
39. The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development.
Zhang W; Mao J; Wang X; Zhao Z; Zhang X; Sun B; Cao Y; Nie M; Wu X
Andrology; 2024 Jan; 12(1):98-108. PubMed ID: 37147882
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation.
Mazen I; Gad YZ; Hafez M; Sultan C; Lumbroso S
Clin Endocrinol (Oxf); 2003 May; 58(5):627-31. PubMed ID: 12699446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
